These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 34563497)
1. Bromodomains: A novel target for the anticancer therapy. Gokani S; Bhatt LK Eur J Pharmacol; 2021 Nov; 911():174523. PubMed ID: 34563497 [TBL] [Abstract][Full Text] [Related]
2. The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins. Taniguchi Y Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827996 [TBL] [Abstract][Full Text] [Related]
3. Bromodomains: Structure, function and pharmacology of inhibition. Ferri E; Petosa C; McKenna CE Biochem Pharmacol; 2016 Apr; 106():1-18. PubMed ID: 26707800 [TBL] [Abstract][Full Text] [Related]
4. BET Bromodomain as a Target of Epigenetic Therapy. Noguchi-Yachide T Chem Pharm Bull (Tokyo); 2016; 64(6):540-7. PubMed ID: 27250788 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of BET bromodomain and other epigenetic acetylrecognition domain-containing factors. Gold S; Shilatifard A Curr Opin Genet Dev; 2024 Jun; 86():102181. PubMed ID: 38564841 [TBL] [Abstract][Full Text] [Related]
6. Bromodomain inhibitors and cancer therapy: From structures to applications. Pérez-Salvia M; Esteller M Epigenetics; 2017 May; 12(5):323-339. PubMed ID: 27911230 [TBL] [Abstract][Full Text] [Related]
7. Bromodomains: a new target class for drug development. Cochran AG; Conery AR; Sims RJ Nat Rev Drug Discov; 2019 Aug; 18(8):609-628. PubMed ID: 31273347 [TBL] [Abstract][Full Text] [Related]
8. Chemical Proteomic Profiling of Bromodomains Enables the Wide-Spectrum Evaluation of Bromodomain Inhibitors in Living Cells. Li X; Wu Y; Tian G; Jiang Y; Liu Z; Meng X; Bao X; Feng L; Sun H; Deng H; Li XD J Am Chem Soc; 2019 Jul; 141(29):11497-11505. PubMed ID: 31246451 [TBL] [Abstract][Full Text] [Related]
9. BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications. To KKW; Xing E; Larue RC; Li PK Molecules; 2023 Mar; 28(7):. PubMed ID: 37049806 [TBL] [Abstract][Full Text] [Related]
10. 3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands. Hewings DS; Wang M; Philpott M; Fedorov O; Uttarkar S; Filippakopoulos P; Picaud S; Vuppusetty C; Marsden B; Knapp S; Conway SJ; Heightman TD J Med Chem; 2011 Oct; 54(19):6761-70. PubMed ID: 21851057 [TBL] [Abstract][Full Text] [Related]
11. Interfering with bromodomain epigenome readers as therapeutic option in mucoepidermoid carcinoma. Markman RL; Webber LP; Nascimento Filho CHV; Reis LA; Vargas PA; Lopes MA; Zanella V; Martins MD; Squarize CH; Castilho RM Cell Oncol (Dordr); 2019 Apr; 42(2):143-155. PubMed ID: 30539410 [TBL] [Abstract][Full Text] [Related]
12. The bromodomain: from epigenome reader to druggable target. Sanchez R; Meslamani J; Zhou MM Biochim Biophys Acta; 2014 Aug; 1839(8):676-85. PubMed ID: 24686119 [TBL] [Abstract][Full Text] [Related]
13. Small-Molecule Targeting of BET Proteins in Cancer. French CA Adv Cancer Res; 2016; 131():21-58. PubMed ID: 27451123 [TBL] [Abstract][Full Text] [Related]
14. Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding Sites. Olp MD; Sprague DJ; Goetz CJ; Kathman SG; Wynia-Smith SL; Shishodia S; Summers SB; Xu Z; Statsyuk AV; Smith BC ACS Chem Biol; 2020 Apr; 15(4):1036-1049. PubMed ID: 32149490 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery. Fu LL; Tian M; Li X; Li JJ; Huang J; Ouyang L; Zhang Y; Liu B Oncotarget; 2015 Mar; 6(8):5501-16. PubMed ID: 25849938 [TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer. Faivre EJ; McDaniel KF; Albert DH; Mantena SR; Plotnik JP; Wilcox D; Zhang L; Bui MH; Sheppard GS; Wang L; Sehgal V; Lin X; Huang X; Lu X; Uziel T; Hessler P; Lam LT; Bellin RJ; Mehta G; Fidanze S; Pratt JK; Liu D; Hasvold LA; Sun C; Panchal SC; Nicolette JJ; Fossey SL; Park CH; Longenecker K; Bigelow L; Torrent M; Rosenberg SH; Kati WM; Shen Y Nature; 2020 Feb; 578(7794):306-310. PubMed ID: 31969702 [TBL] [Abstract][Full Text] [Related]